Identifying a path to improve diagnostic delay and access to care for PSP, CBS, and MSA
Objective: To understand diagnosis and care experiences of patients and care partners living with progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy…Glial neurotrophiz factor as a differential marker of Parkinson`s disease and vascular parkinsonism
Objective: To analysis of glial neurotrophic factor content in blood serum of patients with PD and VP. Background: Parkinson's disease (PD) and vascular parkinsonism (VP)…Analysis of the therapeutic potential of c-Abl inhibition in Multiple System Atrophy
Objective: IkT-148009 is a potent selective inhibitor of non-receptor Abelson Tyrosine Kinases (c-Abl kinases). Our recent analysis of post-mortem brain tissue from patients with Multiple…Operationalising goal setting as an outcome measure: Experience from the PRIME-UK randomised controlled trial
Objective: To select a suitable primary outcome for the evaluation of a multicomponent intervention for people with parkinsonism. Background: The multicomponent PRIME model of care,…Longitudinal free-water changes in dementia with Lewy bodies
Objective: To characterize longitudinal diffusion microstructural changes in individuals with dementia with Lewy bodies (DLB). Background: Diffusion-weighted MRI (dMRI) examines tissue microstructure integrity in vivo.…Referral patterns from primary care physicians to specialists among people with Parkinson’s disease or a Parkinson’s disease–related disorder
Objective: To evaluate referral patterns to a specialist by a primary care provider (PCP) or other healthcare provider (HCP) among people diagnosed with Parkinson’s disease…Parkinsonism and dilated ventricles: not all hydrocephalus is normal-pressure
Objective: We discuss a patient with rapidly progressive parkinsonism with radiological features of normal pressure hydrocephalus, who was diagnosed with obstructive hydrocephalus secondary to intracranial…An Open-Access Model for Parkinson’s Disease Progression
Objective: To model the progression of PD by developing a hidden Markov model which incorporates nonlinear effects of disease severity and medication on clinical scores.…The effect of botulinum toxin on anxiety in cervical dystonia.
Objective: To assess the impact of botulinum toxin injections (BoNT) on anxiety symptoms and motor symptoms in cervical dystonia (CD) during one treatment cycle. Background:…Novel digital marker detects minor hallucinations online at home of patients with Parkinson’s disease
Objective: The aim is to develop a novel implicit and quantitative marker for minor hallucinations (MH) in Parkinson’s disease (PD) for a better tracking of…
- « Previous Page
- 1
- …
- 196
- 197
- 198
- 199
- 200
- …
- 1554
- Next Page »